Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study

Giovanni Cizza, Donna S Ronsaville, Hayley Kleitz, Farideh Eskandari, Sejal Mistry, Sara Torvik, Nina Sonbolian, James C Reynolds, Marc R Blackman, Philip W Gold, Pedro E Martinez, P.O.W.E.R. (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group, Giovanni Cizza, Donna S Ronsaville, Hayley Kleitz, Farideh Eskandari, Sejal Mistry, Sara Torvik, Nina Sonbolian, James C Reynolds, Marc R Blackman, Philip W Gold, Pedro E Martinez, P.O.W.E.R. (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group

Abstract

Background: Major depressive disorder (MDD) has been associated with adverse medical consequences, including cardiovascular disease and osteoporosis. Patients with MDD may be classified as having melancholic, atypical, or undifferentiated features. The goal of the present study was to assess whether these clinical subtypes of depression have different endocrine and metabolic features and consequently, varying medical outcomes.

Methods: Premenopausal women, ages 21 to 45 years, with MDD (N = 89) and healthy controls (N = 44) were recruited for a prospective study of bone turnover. Women with MDD were classified as having melancholic (N = 51), atypical (N = 16), or undifferentiated (N = 22) features. Outcome measures included: metabolic parameters, body composition, bone mineral density (BMD), and 24 hourly sampling of plasma adrenocorticotropin (ACTH), cortisol, and leptin.

Results: Compared with control subjects, women with undifferentiated and atypical features of MDD exhibited greater BMI, waist/hip ratio, and whole body and abdominal fat mass. Women with undifferentiated MDD characteristics also had higher lipid and fasting glucose levels in addition to a greater prevalence of low BMD at the femoral neck compared to controls. Elevated ACTH levels were demonstrated in women with atypical features of depression, whereas higher mean 24-hour leptin levels were observed in the melancholic subgroup.

Conclusions: Pre-menopausal women with various features of MDD exhibit metabolic, endocrine, and BMD features that may be associated with different health consequences.

Trial registration: ClinicalTrials.gov NCT00006180.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Circadian profiles of plasma ACTH,…
Figure 1. Circadian profiles of plasma ACTH, cortisol, and leptin.

References

    1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–27.
    1. Benazzi F. Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study. Psychiatry Res. 1999;86:259–65.
    1. McGinn LK, Asnis GM, Rubinson E. Biological and clinical validation of atypical depression. Psychiatry Res. 1996;60:191–8.
    1. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, et al. Antidepressant specificity in atypical depression. Arch Gen Psychiatry. 1988;45:129–37.
    1. Fountoulakis KN, Iacovides A, Gerasimou G, Fotiou F, Ioannidou C, et al. The relationship of regional cerebral blood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004;3:537–46.
    1. Quitkin FM, Rabkin JG, Stewart JW, McGrath PJ, Harrison W, et al. Sleep of atypical depressives. J Affect Disord. 1985;8:61–7.
    1. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatr. 2002;7:254–75.
    1. Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, et al. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity. J Affect Disord. 1987;12:219–21.
    1. Withall A, Harris LM, Cumming SR. A longitudinal study of cognitive function in melancholic and non-melancholic subtypes of major depressive disorder. J Affect Disord. 2010;123:150–7.
    1. Carragher N, Adamson G, Bunting B, McCann S. Subtypes of depression in a nationally representative sample. J Affect Disord. 2009;113:88–99.
    1. Thase ME. Atypical depression: useful concept, but it's time to revise the DSM-IV criteria. Neuropsychopharmacology. 2009;34:2633–41.
    1. Matza LS, Revicki DA, Davidson JR, Stewart JW. Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry. 2003;60:817–26.
    1. Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, et al. Gender differences in depression: findings from the STAR*D study. J Affect Disord. 2005;87:141–50.
    1. Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, et al. Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry. 2005;66:1002–11.
    1. Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque, et al. The high prevalence of “soft” bipolar (II) features in atypical depression. Compr Psychiatry. 1998;39:63–71.
    1. Posternak MA, Zimmerman M. The prevalence of atypical features across mood, anxiety, and personality disorders. Compr Psychiatry. 2002;43:253–62.
    1. Asnis GM, McGinn LK, Sanderson WC. Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry. 1995;152:31–6.
    1. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 2004;55:1–9.
    1. Cizza G, Ravn P, Chrousos GP, Gold PW. Depression: a major, unrecognized risk factor for osteoporosis? Trends Endocrinol Metab. 2001;12:198–203.
    1. Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, et al. Premenopausal, Osteoporosis Women, Alendronate, Depression (POWER) Study Group. Low bone mass in premenopausal women with depression. Arch Intern Med. 2007;167:2329–36.
    1. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab. 2005;90:2522–30.
    1. Pearson S, Schmidt M, Patton G, Dwyer T, Blizzard L, et al. Depression and insulin resistance: cross-sectional associations in young adults. Diabetes Care. 2010;33:1128–33.
    1. Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW. Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2003;158:1139–47.
    1. Cizza G. Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions. Dialogues Clin Neurosci. 2011;13:73–87.
    1. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders- Patient Edition (SCID I/P), Version 2.0. 1997. Biometrics Research Department.
    1. Eskandari F, Mistry S, Martinez PE, Torvik S, Kotila C, et al. POWER (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism. 2005;54:918–24.
    1. Pande RL, Perlstein TS, Beckman JA, Creager MA. Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation. 2008;118:33–41.
    1. Agresti A. Categorical Data Analysis, 2nd ed. New York: John Wiley & Sons; 2002.
    1. Lamers F, de Jonge P, Nolen WA, Smit JH, Zitman FG, et al. Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2010;71:1582–9.
    1. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;12:3320–5.
    1. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;12:2383–90.
    1. McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, et al. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep. 2009;9:51–9.
    1. Gold PW, Licinio J, Wong ML, Chrousos GP. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann N Y Acad Sci. 1995;771:716–29.
    1. Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry. 1999;4:182–8.
    1. Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011;73:114–26.
    1. Young EA, Carlson NE, Brown MB. Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology. 2001;25:267–76.
    1. Cizza G, Nguyen VT, Eskandari F, Duan Z, Wright EC, et al. Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study. J Clin Psychiatry. 2010;71:1079–87.
    1. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron. 1999;23:775–86.
    1. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M. Interactions between leptin and the human sympathetic system. Hypertension. 2003;41:1072–1079.
    1. Gold PW, Wong ML, Goldstein DS, Gold HK, Ronsaville DS, et al. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci USA. 2005;102:8303–8.
    1. Lu XY. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol. 2007;6:648–52.
    1. Banks WA. Extrahypothalamic effects of leptin: a therapeutic for depression and dementia? Endocrinology. 2011;152:2539–41.
    1. Karapanou O, Papadimitriou A. Determinants of menarche. Reprod Biol Endocrinol. 2010;8:115.
    1. Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Early life menstrual characteristics and pregnancy experiences among women with and without major depression: the Harvard study of moods and cycles. J Affect Disord. 2004;79:167–76.
    1. Cizza G, Primma S, Coyle M, Gourgiotis L, Csako G. Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res. 2010;42:467–82.
    1. Cizza G, Primma S, Csako G. Depression as a risk factor for osteoporosis. Trends Endocrinol Metab. 2009;8:367–73.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe